Clinical Pharmacology and Therapeutic Potential of Monoclonal Antibody Treatment in Rheumatoid Arthritis

被引：0
|
作者：
Ernest H. S. Choy
机构：
[1] Guy’s and King’s College Hospitals,Rheumatology Unit
[2] Guy’s Hospital,Rheumatology Unit, 5th Floor, Thomas Guy House
来源：
Drugs & Aging | 1998年 / 12卷
关键词：
Rheumatoid Arthritis; Adis International Limited; Synovial Fluid; Rheumatol; Synovial Joint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Many monoclonal antibodies (mAb) have been tested in rheumatoid arthritis (RA). Murine antibodies were antigenic and caused human antimouse responses in the recipients. As a result, re-treatments were less effective and were associated with an increased risk of anaphylaxis. Advances in biotechnology have allowed us to develop chimaeric and humanised mAb that are less antigenic than their murine equivalents.
引用
收藏
页码：139 / 148
页数：9
相关论文
共 50 条
  • [41] Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis
    Yanying Liu
    Rong Mu
    Shiyao Wang
    Li Long
    Xia Liu
    Ru Li
    Jian Sun
    Jianping Guo
    Xiaoping Zhang
    Jing Guo
    Ping Yu
    Chunlei Li
    Xiangyuan Liu
    Zhenyu Huang
    Dapeng Wang
    Hu Li
    Zhifeng Gu
    Bing Liu
    Zhanguo Li
    Arthritis Research & Therapy, 12
  • [42] Therapeutic potential of IL-15 in rheumatoid arthritis
    Yang, Xiao-Ke
    Xu, Wang-Dong
    Leng, Rui-Xue
    Liang, Yan
    Liu, Yan-Yan
    Fang, Xin-Yu
    Feng, Chen-Chen
    Li, Rui
    Cen, Han
    Pan, Hai-Feng
    Ye, Dong-Qing
    HUMAN IMMUNOLOGY, 2015, 76 (11) : 812 - 818
  • [43] Therapeutic Potential of Sclareol in Experimental Models of Rheumatoid Arthritis
    Tsai, Sen-Wei
    Hsieh, Ming-Chia
    Li, Shiming
    Lin, Shih-Chao
    Wang, Shun-Ping
    Lehman, Caitlin W.
    Lien, Christopher Z.
    Lin, Chi-Chien
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (05)
  • [44] Galangin: A Promising Flavonoid for the Treatment of Rheumatoid Arthritis-Mechanisms, Evidence, and Therapeutic Potential
    Khawaja, Ghada
    El-Orfali, Youmna
    Shoujaa, Aya
    Abou Najem, Sonia
    PHARMACEUTICALS, 2024, 17 (07)
  • [45] Traditional Tibetan medicine: therapeutic potential in rheumatoid arthritis
    Yu, Liqiong
    Li, Shiling
    Pu, Lili
    Yang, Chunhong
    Shi, Qian
    Zhao, Qi
    Meniga, Shengbu
    Liu, Yue
    Zhang, Yi
    Lai, Xianrong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] Immunodiagnosis and therapeutic immunosuppression in rheumatoid arthritis with ior t1 (anti-CD6) monoclonal antibody
    E Montero
    G Reyes
    M Guibert
    O Torres
    N Rodriguez
    J Estrada
    L Torres
    R Perez
    A Hernandez
    A Lage
    Arthritis Research & Therapy, 4 (Suppl 1)
  • [47] Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis
    Kay, Jonathan
    Rahman, Mahboob U.
    CORE EVIDENCE, 2009, 4 : 159 - 170
  • [48] CLAZAKIZUMAB Humanized Anti-IL-6 Monoclonal Antibody Treatment of Rheumatoid Arthritis Treatment of Autoimmune Diseases Oncolytic
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (09) : 633 - 636
  • [49] Blood vessels, a potential therapeutic target in rheumatoid arthritis?
    Semerano, Luca
    Clavel, Gaelle
    Assier, Eric
    Denys, Anne
    Boissier, Marie-Christophe
    JOINT BONE SPINE, 2011, 78 (02) : 118 - 123
  • [50] Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: An exploratory analysis
    Ortea, Ignacio
    Roschitzki, Bernd
    Gabriel Ovalles, Juan
    Lopez Longo, Javier
    de la Torre, Inmaculada
    Gonzalez, Isidoro
    Gomez-Reino, Juan J.
    Gonzalez, Antonio
    JOURNAL OF PROTEOMICS, 2012, 77 : 372 - 382
12345